Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS)
CNY 4.77
(0.0%)
CNY 4.77
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 898.64 Million | 1.15 Billion | 889.93 Million | 1.24 Billion | 925.5 Million | 545.77 Million |
| Net Income | 674.72 Million | 460.08 Million | 2.11 Billion | 549.19 Million | -271.51 Million | 808.33 Million |
| Depreciation & Amortization | 324.34 Million | 277.48 Million | 277.59 Million | 266.07 Million | 261.21 Million | 240.4 Million |
| Deferred income taxes | -83.99 Million | -9.44 Million | 238.46 Million | 66.01 Million | 44.43 Million | 12.06 Million |
| Stock-based compensation | 26.35 Million | 4.8 Million | 30.16 Million | 30.16 Million | 30.16 Million | 30.16 Million |
| Change in working capital | -241.71 Million | 173.67 Million | 87.65 Million | 421.83 Million | -211.78 Million | -691.28 Million |
| Other non-cash items | 41.14 Million | 248.88 Million | -1.86 Billion | -83.58 Million | 1.07 Billion | 188.31 Million |
| Investing Cash Flow | -289.05 Million | -211.11 Million | 1.1 Billion | -166.76 Million | -141.41 Million | -1.7 Billion |
| Investments in PPE | -209.14 Million | -291.75 Million | -568.37 Million | -460.39 Million | -268.78 Million | -379.63 Million |
| Acquisitions | 8.78 Million | -206.31 Million | 1.47 Billion | 13.5 Million | -97.6 Million | -107.27 Million |
| Investment purchases | -444.99 Million | -12.64 Thousand | -45 Million | -50 Million | -18 Million | -1.24 Billion |
| Sales/Maturities of investments | 312.37 Million | 67.42 Million | 81.53 Million | 118.79 Million | 146.17 Million | 391.08 Million |
| Other Investing Activities | -43.62 Million | 219.53 Million | 153.28 Million | 211.32 Million | 96.8 Million | -370.18 Million |
| Financing Cash Flow | -719.08 Million | -924.7 Million | -1.01 Billion | -1.02 Billion | -626.52 Million | 202.84 Million |
| Debt repayment | -44.78 Million | -2.05 Billion | -2.78 Billion | -3.71 Billion | -3.38 Billion | -1.32 Billion |
| Dividends payments | -420.12 Million | -490.34 Million | -85.01 Million | -142.8 Million | -385.5 Million | -485.45 Million |
| Common Stock Repurchased | - | - | - | - | -273.78 Million | -311.36 Million |
| Common Stock Issuance | - | - | - | - | 273.78 Million | - |
| Other Financing Activities | -301.9 Million | 1.62 Billion | 1.84 Billion | 2.83 Billion | 3.27 Billion | 2.01 Billion |
| Accounts receivables | -271.44 Million | 47.94 Million | -360.46 Million | 177 Million | 73.15 Million | -631.47 Million |
| Accounts payables | 358.68 Million | 246.19 Million | 341.5 Million | -60.53 Million | -223.44 Million | 207.4 Million |
| Inventory | -244.96 Million | -111.02 Million | -129.79 Million | 239.35 Million | -105.93 Million | -277.75 Million |
| Other working capital | 26.35 Million | -9.44 Million | 236.4 Million | 66.01 Million | 44.43 Million | -413.52 Million |
| Cash at beginning of period | 2.43 Billion | 2.4 Billion | 1.39 Billion | 1.34 Billion | 1.19 Billion | 2.13 Billion |
| Cash at end of period | 2.32 Billion | 2.43 Billion | 2.36 Billion | 1.39 Billion | 1.34 Billion | 1.17 Billion |
| Capital Expenditure | -209.14 Million | -291.75 Million | -568.37 Million | -460.39 Million | -268.78 Million | -379.63 Million |
| Effect of forex changes on cash | 2.98 Million | 9.11 Million | 45.6 Thousand | -6.24 Million | -6.04 Million | 964.5 Thousand |
| Net cash flow / Change in cash | -106.5 Million | 28.77 Million | 974.96 Million | 48.92 Million | 151.52 Million | -957.44 Million |
| Free Cash Flow | 689.49 Million | 863.73 Million | 321.56 Million | 789.3 Million | 656.71 Million | 166.14 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 136.25 Million | 166.13 Million | 216.06 Million | -31.66 Million | 674.72 Million | 107.1 Million |
| Depreciation & Amortization | - | 86.1 Million | 86.1 Million | 317.23 Million | 324.34 Million | -150.43 Million |
| Deferred income taxes | - | - | - | - | -83.99 Million | -271.68 Million |
| Stock-based compensation | - | 13.47 Million | - | 26.35 Million | 26.35 Million | -14.39 Million |
| Change in working capital | - | -133.55 Million | - | -490.05 Million | -241.71 Million | 425.99 Million |
| Other non-cash items | 18.3 Million | 96.3 Million | -54.76 Million | 418.34 Million | 41.14 Million | 122.8 Million |
| Investing Cash Flow | -135.67 Million | -137.04 Million | -32.4 Million | -94.94 Million | -289.05 Million | 13.29 Million |
| Investments in PPE | -47.79 Million | -38.35 Million | -64.38 Million | -67.76 Million | -209.14 Million | -57.67 Million |
| Acquisitions | 11.98 Million | 1.31 Million | 6.02 Million | 8.78 Million | 8.78 Million | 55.05 Million |
| Investment purchases | 525.27 Million | -700.51 Million | - | -52.41 Million | -444.99 Million | -55.05 Million |
| Sales/Maturities of investments | -625.14 Million | 600.5 Million | 25.95 Million | -935.64 Thousand | 312.37 Million | 15.91 Million |
| Other Investing Activities | 11.98 Million | -66.26 Million | 31.98 Million | -35.97 Million | -43.62 Million | 55.05 Million |
| Financing Cash Flow | -528.02 Million | -1.11 Billion | -293.1 Million | 39.74 Million | -719.08 Million | -563.19 Million |
| Debt repayment | -180.23 Million | -450.59 Million | -164.97 Million | -238.48 Million | -44.78 Million | -770.47 Million |
| Dividends payments | -503.72 Million | -503.72 Million | -8.57 Million | -8.05 Million | -420.12 Million | -8.56 Million |
| Common Stock Repurchased | - | -268 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -341.92 Million | -160.58 Million | -119.55 Million | -190.69 Million | -301.9 Million | 215.84 Million |
| Accounts receivables | - | -163.91 Million | - | -271.44 Million | -271.44 Million | 384.95 Million |
| Accounts payables | - | - | - | - | 358.68 Million | 14.39 Million |
| Inventory | - | 15.95 Million | - | -244.96 Million | -244.96 Million | 41.03 Million |
| Other working capital | - | 14.4 Million | - | 26.35 Million | 26.35 Million | -14.39 Million |
| Cash at beginning of period | 1.08 Billion | 2.36 Billion | 2.32 Billion | 2.14 Billion | 2.43 Billion | 2.47 Billion |
| Cash at end of period | 574.42 Million | 1.38 Billion | 2.16 Billion | 2.32 Billion | 2.32 Billion | 2.14 Billion |
| Capital Expenditure | -47.79 Million | -38.35 Million | -64.38 Million | -67.76 Million | -209.14 Million | -57.67 Million |
| Effect of forex changes on cash | -1.81 Million | 462.91 Thousand | 28.6 Thousand | 986.86 Thousand | 2.98 Million | -409.92 Thousand |
| Net cash flow / Change in cash | -512.27 Million | -979.13 Million | -164.17 Million | 186 Million | -106.5 Million | -330.91 Million |
| Free Cash Flow | 106.76 Million | 137.97 Million | 96.91 Million | 172.46 Million | 689.49 Million | 161.71 Million |
2157
TPS
TIG
TPST
8957
ISUR